G Medical Innovations Holdings Management
Management criteria checks 2/4
G Medical Innovations Holdings' CEO is Yacov Geva, appointed in Oct 2014, has a tenure of 10.25 years. directly owns 5.31% of the company’s shares, worth $14.01. The average tenure of the management team and the board of directors is 4.9 years and 7.9 years respectively.
Key information
Yacov Geva
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 10.3yrs |
| CEO ownership | 5.3% |
| Management average tenure | 4.9yrs |
| Board average tenure | 7.9yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2022 | n/a | n/a | -US$14m |
| Sep 30 2022 | n/a | n/a | -US$18m |
| Jun 30 2022 | n/a | n/a | -US$23m |
| Mar 31 2022 | n/a | n/a | -US$19m |
| Dec 31 2021 | n/a | n/a | -US$14m |
| Sep 30 2021 | n/a | n/a | -US$13m |
| Jun 30 2021 | n/a | n/a | -US$12m |
| Mar 31 2021 | n/a | n/a | -US$12m |
| Dec 31 2020 | n/a | n/a | -US$13m |
| Sep 30 2020 | n/a | n/a | -US$13m |
| Jun 30 2020 | n/a | n/a | -US$13m |
| Mar 31 2020 | n/a | n/a | -US$14m |
| Dec 31 2019 | US$360k | US$360k | -US$15m |
| Sep 30 2019 | n/a | n/a | -US$15m |
| Jun 30 2019 | n/a | n/a | -US$15m |
| Mar 31 2019 | n/a | n/a | -US$15m |
| Dec 31 2018 | US$360k | US$360k | -US$16m |
Compensation vs Market: Insufficient data to establish whether Yacov's total compensation is reasonable compared to companies of similar size in the US market.
Compensation vs Earnings: Insufficient data to compare Yacov's compensation with company performance.
CEO
Yacov Geva (74 yo)
10.3yrs
Tenure
US$360,000
Compensation
Dr. Yacov Geva serves as the Chief Executive Officer, President and Executive Director of G Medical Innovations Holdings Limited since October 3, 2014 and served as its Managing Director. Dr. Geva was the...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Executive Director | 10.3yrs | US$360.00k | 5.31% $ 14.0 | |
| CFO & Controller | 1.2yrs | US$116.52k | no data | |
| Vice President of Operations | less than a year | no data | no data | |
| VP of R&D Corporate and CTO Corporate | 4yrs | no data | 0.00062% $ 0.002 | |
| Senior VP of Mergers & Acquisitions Corporate | 7.5yrs | no data | 0.00086% $ 0.002 | |
| Executive Vice President of US Operations | 6yrs | no data | 0.00060% $ 0.002 | |
| Company Secretary | 4.9yrs | no data | no data |
4.9yrs
Average Tenure
65yo
Average Age
Experienced Management: GMVD.F's management team is considered experienced (4.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Executive Director | 10.3yrs | US$360.00k | 5.31% $ 14.0 | |
| Independent Non-Executive Director | 7.9yrs | US$71.20k | 0.00063% $ 0.002 | |
| Independent Non-Executive Director | 7.9yrs | US$71.20k | 0.00071% $ 0.002 | |
| Independent Non-Executive Chairman | 10.4yrs | US$71.20k | 0.0022% $ 0.006 | |
| Independent Director | 3.6yrs | no data | 0.000080% $ 0.0002 | |
| Independent Non-Executive Director | 5.8yrs | US$73.59k | 0.00075% $ 0.002 |
7.9yrs
Average Tenure
72yo
Average Age
Experienced Board: GMVD.F's board of directors are considered experienced (7.9 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/05 05:50 |
| End of Day Share Price | 2025/01/02 00:00 |
| Earnings | 2022/12/31 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
G Medical Innovations Holdings Ltd is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ishan Majumdar | Baptista Research |
| Constantine Davides | D. Boral Capital LLC. |
| Ashok Kumar | ThinkEquity LLC |